Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by:
Daniels, Craig E., M.D.
ClinicalTrials.gov Identifier:
NCT00131274
First received: August 17, 2005
Last updated: October 4, 2005
Last verified: August 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given
No publications provided by Daniels, Craig E., M.D.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):